Altaroc
Companies
Equashield
Manager
Fund |
Manager |
Co-invested company
sector
Healthcare
regional split
Rest of the world
vintage
status
Portfolio
category
Unicorn
Nordic Capital XI
Nordic Capital

Equashield

Co-invested company
Equashield is one of the world's leading providers of technology for the preparation and delivery of hazardous drugs.
Products of Equashield, part of the Private Equity manager's portfolio Nordic Capital

Equashield key figures

2009
year of inception
+ 25
country
+ 450
employees
+ 3000
corporate customers worldwide
Data as at
20/3/26
*Source: Public data from companies’ websites and social media accounts. For more up-to-date information, we invite our investors to view the report made available on their space.

The Altaroc Odyssey 2021 fpci is closed for business.

About Equashield

Equashield has established itself as a major player in the field of manual and automated technologies for the preparation and administration of hazardous drugs worldwide. Its Closed System Transfer Device (CSTD) offers unprecedented safety and ease of use for healthcare professionals dealing with these potentially harmful substances.

Designed to limit the exposure of hazardous drugs to the outside environment, Equashield CSTDs are clinically recognized for their effectiveness in protecting healthcare workers. The world-renowned Equashield II device stands out for its ability to prevent contamination by drug residues and reduce exposure to vapors emanating from these substances.

Studies have confirmed the superiority of Equashield's CSTDs in terms of speed and ease of use, compared with alternatives available on the market. With a team of 400 employees, the company has also launched Equashield Pro, an innovative solution designed to make automation technologies accessible and easy to integrate into hospital pharmacies.

With a footprint and size comparable to those of a standard biological safety cabinet, Equashield Pro enables efficient and accurate preparation of patient-specific chemotherapy doses. Its verification software reduces the risk of incidents and errors when handling hazardous drugs.

With sales growing steadily, reaching 105 million euros by 2022, Equashield confirms its position as a leader in its field, demonstrating its ability to meet the growing need for safety in the handling of sensitive medical substances.

In the same sector as Equashield

Company videos
No items found.

Discover the new Vintage Altaroc Odyssey 2025

Discover the Vintage Altaroc Horizon

Nordic Capital
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.